![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Virological Suppression in People With HIV-1 (PWH) Receiving Dolutegravir/Lamivudine Was High and Similar Across Age Groups Despite Older PWH Having Increased Rates of Comorbidities and Polypharmacy (TANDEM Subgroup Analysis)
|
|
|
ID Week Oct 11 2023
Andrew P. Brogan,1 Jihad Slim,2 Gustavo Verdier,3 Gavin Harper,4 Katie Mycock,4 Hannah Wallis,4 Cynthia Donovan1
1ViiV Healthcare, Durham, NC, USA; 2New York Medical College, Valhalla, NY, USA; 3ViiV Healthcare, Montreal, Canada; 4Adelphi Real World, Bollington, UK
![1012231](../images/101023/101023-2/1012231.gif)
![1012232](../images/101023/101023-2/1012232.gif)
![1012233](../images/101023/101023-2/1012233.gif)
![1012234](../images/101023/101023-2/1012234.gif)
![1012235](../images/101023/101023-2/1012235.gif)
![1012236](../images/101023/101023-2/1012236.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|